Incidence of HPV-Positive Head and Neck Cancer Up in the U.S.
From 2013 to 2014, incidence of HPV-positive oropharyngeal cancers was 4.62 per 100,000 persons.
Diagnosis & Disease Information
Men Less Knowledgeable About HPV, HPV Vaccination
Most men and women did not know anal, penile, and oral cancers are caused by HPV.
Incidence, Age at Diagnosis Increasing in HPV-Positive Oropharyngeal Squamous Cell Carcinoma
A retrospective study demonstrates an increase in HPV16-positive status among patients with OPSCC and a corresponding increase in age at diagnosis.
Age, Race, Sex Affect Survival for Patients With HPV-Associated Cancers
Using a data sample from the CDC National Program for Cancer Registries, investigators determined how demographic factors — age, race, and sex — impact 5-year survival rates for HPV-associated cancers from initial diagnosis until death.
Pembrolizumab Use With CRT Safe in Locally Advanced HNSCC
Small study also showed that pembrolizumab does not significant impair radiation or chemotherapy dosing.
Presence of Protein E6 Predictive of Oropharyngeal Cancer Risk in HPV16-Infected Persons
Protein produced by chronically infected cells in persons with HPV16 infection serves as a biomarker for risk of cancer of the oropharynx.
Parental Self-persuasion in Low-Income Groups Improves HPV Vaccination Rates
Self-persuasion is more effective than external persuasion for motivating low-income parents to vaccinate their children against HPV.
HPV Vaccination Program Reduces Cervical Cell Anomalies in Young Women
Fewer cervical cell anomalies were present on cervical cancer screens of young women in Canada who received the HPV vaccine through a school-based program.
Blood antibodies may predict survival of HPV-positive oropharyngeal cancer
The presence of certain human papillomavirus (HPV)-16 antibodies in the blood is associated with improved survival rates for patients with HPV-related oropharyngeal carcinoma.
HPV-positive oropharyngeal cancer has cure potential
A prospective study found that patients with human papillomavirus-related disease had better treatment response than HPV-negative patients.
- Loading...
Loading...
Next post in Issues in Cancer Survivorship
Loading... 
Loading...